This may be mitigated by the increased dependency of leukemia cells to c-MYB expression [20, 21] and by inhibition of mechanisms regulating the expression and function of c-MYB critical in AML but to a lesser extent in normal hematopoietic cells [22]. The gene discussed is MYB; the disease is leukemia.